Cargando…
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Ejemplares similares
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
por: van der Lee, Sven J., et al.
Publicado: (2019) -
ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018) -
Differential insular cortex subregional vulnerability to α‐synuclein pathology in Parkinson's disease and dementia with Lewy bodies
por: Fathy, Y. Y., et al.
Publicado: (2018) -
Autoimmune Encephalitis Resembling Dementia Syndromes
por: Bastiaansen, Anna E.M., et al.
Publicado: (2021) -
Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
por: Coomans, Emma M., et al.
Publicado: (2023)